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Abstract 28 
The electroanalytical sensing of albendazole and mebendazole based on Perovskite-Type 29 
LaFeO3 nanoparticles modified sonogel carbon paste electrodes has been reported for the first time. 30 
The electroanalytical protocol was successfully applied for the sensing of albendazole and 31 
mebendazole in pharmaceutical formulations. Benzimidazoles, such as albendazole and 32 
mebendazole, are common anthelmintic agents, diffusely used throughout the world against 33 
parasitic diseases.  34 
Modified sonogel carbon paste electrodes with Perovskite-type LaFeO3 nanoparticles exhibits 35 
higher electrocatalytic activity and sensitivity towards the detection of albendazole and 36 
mebendazole compared to the unmodified electrode.  37 
The limits of detection for albendazole and mebendazole were reported to be 0.3 µM and 0.6 µM 38 
respectively and the limits of quantification 0.8 µM and 1.7 µM respectively.  39 
Provskite-type LaFeO3 nanoparticles were characterized by X-ray diffraction (XRD), fourier 40 
transform infrared (FTIR), scanning electron microscopy (SEM) and transmission electron 41 
microscopy (TEM).  42 
 43 
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1. Introduction 71 
 72 
Helminthic infections are widespread in tropical countries, leading to sub growth of children, 73 
lowering their cognitive and intellectual performance, decreasing the work force and thus 74 
contributing to underdevelopment of nation. Therefore, besides the relevant health problems related 75 
to the malnutrition and anemia, such parasitic worms impact the socioeconomic status of endemic 76 
countries [1,2]. 77 
The control of intestinal parasites have been done mostly by the benzimidazoles, in which 78 
albendazole (AB) and mebendazole (MB) are remarkable examples, that combine therapeutic 79 
efficiency, broad spectrum of activity, low side effects even at large doses with low cost [1,3,4]. 80 
The benzimidazoles interact with β-tubulin, a eukaryotic cytoskeletal protein, thus inhibiting its 81 
polymerization into microtubules and hampering the cell motility, intracellular transport of 82 
cytoplasmic particles among other important biochemical functions [5]. Figure 1 depicts the 83 
chemical structures of AB and MB. AB and MB also exert their mode of action by avoiding the 84 
glucose captivation and by inducing some oxidative stress [1,6,].  85 
Figure 1 86 
Though AB presents activity against many intestinal parasites, the use to combat larval forms of 87 
Taenia solium, that is associated to neurocysticercosis, a brain infection is one of its therapeutic 88 
applications of utmost importance [7,8]. 89 
In turn, MB has been proved to be a very useful chemotherapeutic agent with high cure rates against 90 
nematodes and being very well tolerated in mammalians [3,6,9]. Hence, taking into account the 91 
great consume of both anthelmintic agents, their quantitative determination in pharmaceutical 92 
formulations is of great importance. 93 
Literature reveals that, chromatography with UV detection has been the predominant method for 94 
quantification of AB and MB in different matrices [3,7,10,11]. Nevertheless, the chromatography is 95 
marked by overall high cost, which includes laborious optimization of assay conditions, frequent 96 
necessity of sample pre-treatment, both leading to elevated time-consuming, and also the 97 
requirement of columns, chemical standards and HPLC grade solvents, all very expensive [6,8,9]. 98 
On the other hand, UV spectrophotometry [12] and non-aqueous titrimetry [13] respectively, for 99 
small and large amounts of these drugs are methods that eventually fail by lack of the suitable 100 
accuracy, precision, sensibility and selectivity. In turn, the electroanalytical methods, are recognized 101 
by their great sensitivity, modular selectivity, creativity due to no need for pre-treatment or pre-102 
separation, reduced cost for acquisition and/or maintenance of equipment and accessories and eco 103 
friendly low consume of reagents [8,9,14]. 104 
However, despite all mentioned advantages few papers concerned to electroanalysis of AB have 105 
been published [7,8,15,16] and even fewer for MB [6,9,13,17]. Among such works, the use of 106 
conventional electrodes, i.e. dropping mercury [6,13], boron-doped diamond electrode [8], glassy 107 
carbon (GC) rotating disk electrode [7], and just only one graphene modified electrode [9,18] keep 108 
open the search for nanostructured electrodic materials. 109 
Sonogel carbon electrodes (SNGCEs) are very attractive for electrochemical studies mainly due to 110 
properties such as low cost, good reproducibility, good mechanical rigidity and easy manufacture 111 
and modification broadening their applicability and sensitivity [19,20]. Indeed, for the fabrication of 112 
efficient electrochemical sensors, several materials have been employed in order to enhance the 113 
reproducibility, stability, sensitivity and selectivity. Since nanostructured metal oxides confer high 114 
electron transfer kinetics and enhancement of electroactive surface area, decreasing the required 115 
over potential and as consequence increasing the selectivity and sensibility, such materials are very 116 
promising [21-24].  117 
LaFeO3 is a p-type semiconductor catalytic material of perovskite-structure (ABO3) that hold many 118 
favorable physical and chemical properties, including narrow band gap (1.2 eV), good electrical 119 
conductivity and high electrochemical stability. Besides the excellent catalytic properties, LaFeO3 120 
can be used as an electrocatalyst on the fabrication of efficient electrodic materials for sensing 121 
electroactive species [22,25].  122 
Thus, the aim of the present study was the development of LaFeO3 sonogel carbon paste modified 123 
electrodes for the electroanalytical determination of AB and MB in pharmaceutical formulations. 124 
To the best of our knowledge this is the first manuscript to report the electroanalytical sensing of 125 
albendazole and mebendazole in pharmaceutical formulations utilizing modified sonogel carbon 126 
paste electrodes with Perovskite-Type LaFeO3 Nanoparticles. 127 
 128 
2. Materials and Methods 129 
2.1 Materials 130 
Fe(NO3)3.9H2O was purchased from Vetec Química (Brazil), starch was purchased from 131 
Synth(Brazil) and methyltrimethoxysilane (MTMOS) was purchased Merck (Darmstad, Germany). 132 
La(CH3COO)3.1.5H2O was prepared by reported procedure [25,26] and water content was 133 
determined by thermogravimetric analysis (TGA). All other chemicals and solvents were of reagent 134 
grade and were used without further purification.  Electrolyte solutions were prepared by using high 135 
analytical grade salts, which were diluted in double distilled Milli-Q water (conductivity ≤ 136 
0.1µScm-1) (Millipore S. A., Molsheim, France). AB and MB of analytical grade were obtained 137 
from Sigma (Saint Louis, USA). AB and MB tablets, (containing 400 mg of the active 138 
pharmaceutical principle) were purchased from a local pharmacy. Stock solutions of AB and MB 139 
were freshly prepared immediately prior to the experiments in ethanol.  Glass capillary tubes, i.d. 140 
1.15 mm, were used as the bodies for the composite electrodes. 141 
2.2 Instrumentation  142 
The TGA of the sample was performed under nitrogen (50 cm3min-1) on a thermogravimetric (TG) 143 
instruments system, model Shimadzu DTG- 60/60H. X-ray diffraction (XRD) measurements of the 144 
nanosized powder LaFeO3 were recorded in the range 10-80° (2θ) using a Shimadzu (XRD-6000) 145 
system equipped with the Cu Kα radiation source. The XRD data were refined using the PowderX 146 
software and the cell parameters were calculated using the Unitcell software applied to the peak 147 
positions of all major reflections. The average diameter of the nanocrystalline domains was 148 
determined from the full-width at half-maximum (fwhm) of the strongest reflection peak (112 149 
reflections) using the Scherrer’s equation. The scanning electron microscope (SEM) image and 150 
energy dispersive X-ray Spectroscopy (EDS) were obtained on Jeol JSM 6610 microscope equipped 151 
with EDS Thermo scientific NSS Spectral Imaging. Transmission electron microscope analysis 152 
(TEM) were obtained on Jeol JEM 2100 equipped with EDS Thermo scientific at an acceleration 153 
voltage of 200 kV by placing the powder on a copper grid to observe the morphology and size of 154 
the powders. 155 
Voltammetric experiments were carried out with a potentiostat/galvanostat µAutolab III ® 156 
integrated to   the GPES 4.9® software, Eco-Chemie, Utrecht, The Netherlands. The measurements 157 
were performed  in  a  5.0  mL  one-compartment  electrochemical  cell,  with a  three-electrode  158 
system consisting  of  a  Sonogel modified electrode, a  Pt wire and the Ag/AgCl/KCl 3M, 159 
representing the working, the counter and the reference electrodes, respectively. 160 
The experimental conditions for differential pulse voltammetry (DPV) were: pulse amplitude 50 161 
mV, pulse width 0.5 s and scan rate 10 mV s-1. The experimental conditions for cyclic voltammetry 162 
(CV) were: scan rate of 100 mV s-1 and scan range from 0 to 1.0 V. The DP voltammograms were 163 
background-subtracted and baseline-corrected, and all voltammetric data were analyzed and treated 164 
with the software Origin 6®.  165 
All experiments were done at room temperature (21±1ºC) in triplicate (n = 3) and the main 166 
electrolyte used was the phosphate buffer (PBS). 167 
 168 
2.3 Preparation of LaFeO3 Nanoparticles 169 
LaFeO3 was prepared according to a modified procedures described in previous literature [25,26]. 170 
Briefly, lanthanum(III) acetate hydrate (6 mM) and Fe(NO3)3·9H2O (6 mM) were dissolved in 15 171 
mL water and 0.5 g soluble starch was added. The turbid solution was continuously stirred at room 172 
temperature and after 15 min the heating plate was raised to about 120°C. After about 5 min the 173 
solution turned to a highly viscous orange gel. This (LaFeO3)-gel was calcined in static air at 570°C 174 
(heating rate 5°C /min) for 2 h yielded a nano-sized LaFeO3 powder. 175 
 176 
2.4  Fabrication of Sonogel electrode modified with LaFeO3  nanoparticles 177 
To prepare the SNGCE, the general procedure was as follows: a mixture of 500 µL of MTMOS and 178 
100 µL of a 0.2 M HCl solution was insonated for 10 s. Next, 0.5 g of graphite powder was added 179 
and dispersed homogeneously in the sonosol obtained. After several minutes, once the resulting 180 
material had acquired enough consistency the glass capillary tubes were filled, leaving a little extra 181 
mixture sticking out of the glass tube to facilitate the ulterior polishing step. After 24 h, the 182 
Sonogel-Carbon electrodes were hardened and, therefore, structured. Before use, the electrodes 183 
were polished with nº 1200 emery paper to remove extra composite material and wiped gently with 184 
weighing paper. Electrical contact was established by inserting a copper wire into the capillary 185 
tubes. Glass capillary tubes, i.d. 1.15 mm, were used as the bodies of the composite electrodes. The 186 
LaFeO3 modified SNGE was constructed by adding 3μL aliquot of this dispersion solution (1%) 187 
was chosen as the modifying amount and dropped onto the surface of the bare sonogel carbon 188 
electrode and dried in air at room temperature, forming the modified electrode. 189 
 190 
 191 
2.5 Preparation of standard and real samples 192 
A stock solution of AB and MB (10-3M) were freshly prepared and used as the stock solution by 193 
dissolving it in ethanol by ultrasonic waves. These solutions were diluted up to the required 194 
concentrations with the same solvent. Ten pharmaceutical tablets of AB and MB, labeled with 195 
amount of 400 mg (AB) and 500 mg (MB) per tablet, were completely powdered and amount of 196 
average weight of one tablet was weighted. Afterwards, a suitable amount of each sample was 197 
weighed and transferred to a volumetric flask, whose remaining volume was completed with 198 
deionized water to obtain the AB and  MB stock solutions for each sample. These solutions were 199 
subjected to sonication for 10 min and then the non-dissolved solids were filtered off. Aliquots of 200 
each of the stock solutions were directly added to the supporting electrolyte solution in the 201 
electrochemical cell and the respective voltammograms were recorded.  202 
For the determination of albendazole in syrup (40 mg AB per 10 mL), the samples were further 203 
diluted to achieve the concentration of AB in the working range. The samples were then spiked with 204 
appropriate amount of AB for the experiments. The standard addition method was used for 205 
analyzing the pharmaceutical samples of AB and MB for the validation of the sensor. 206 
 207 
3. Results and Discussion 208 
3.1 Characterization of LaFeO3 nanocrystals 209 
Figure 2A shows the X-ray powder diffraction pattern of the LaFeO3 sample, which indicates the 210 
formation of monophase perovskite oxides having orthorhombic structure, the diffraction data are in 211 
good agreement with JCPDS card of LaFeO3 (JCPDS 37-1493). The average particle size of the 212 
LaFeO3 nanocrystals was about 20 nm estimated from the XRD pattern parameters according the 213 
Scherrer equation [27,29]. The FT-IR spectrum (Figure 2B) of sample displays strong absorption 214 
bands about 550-400 cm-1 indicating the formation of lanthanum ferrite. The 570 cm-1 band is 215 
attributed to the Fe–O stretching vibration. Also, can be see weak bands in the 1300–1500 cm-1 216 
regions which are attributable to carbonate groups [30], despite not having been detected carbonates 217 
by XRD [27]. 218 
Figure 2 219 
The TEM images of Figure 3 indicate the presence of agglomerates of porous LaFeO3 220 
nanoparticles. The individual particles are mainly in the range of about 60 to 100 nm, but also have 221 
been found particles up to about 200 nm, as previously reported in the literature [30].  222 
Figure 3 223 
The microstructure LaFeO3 powder can be visualized from SEM Figure 4A and 4B. SEM images of 224 
LaFeO3 powder show that the particles’ morphology are most irregular in shape. As a result some 225 
particles are found to form macro-agglomerations. The particle shapes are not well defined as there 226 
are many large and small pores present in the whole material with range of ca. 30 to 70 nm. 227 
Figure 4 228 
The elemental analysis of the sample was carried out by using EDS and is shown in Figure 4C. The 229 
EDS result clearly shows that LaFeO3 contains La, Fe, and O without any impurity and quantitative 230 
analysis verified that doping with lanthanum is close to the expected concentration. 231 
 232 
3.2 Electrocatalytic response of LaFeO3 sonogel based electrodes 233 
The optimum amount of LaFeO3 (1 to 10 % of total paste) on the electro catalytic performance was 234 
evaluated. The effect of LaFeO3 on the electrode performance was expressive even at the small 235 
proportion, thus taking into account the cost effectiveness, thus only 1% of metal oxide shown to be 236 
enough. 237 
Moreover the pH of the electrolyte was also investigated over the pH range from 3 to 8. It was 238 
found that the highest sensitivity was observed at pH 5 (Figure 5). Therefore, further assays were 239 
performed at pH 5.0.  240 
The Figure 5 shows the anodic response of SNGE and LaFeO3-SNGE electrodes against AB and 241 
MB.  242 
Figure 5 243 
Figure 5 a) and b) shows the effect of the incorporation of nanosized LaFeO3 to SNGE which leads 244 
to expressive enhancement of electrocatalytic activity for both benzimidazoles. 245 
Thus the LaFeO3 modified SNGE was used for quantitative determinations of AB and MB in 246 
pharmaceutical formulations. 247 
 248 
3.3 The effect on concentration 249 
Next, the effect of albendazole and mebendazole concentration on perovskite-type 250 
LaFeO3 nanoparticles modified sonogel carbon paste electrodes was investigated. A range of AB 251 
and MB concentrations from 1 to 10.5 μM and from 2.3 to 10.0 μM respectively was explored in 252 
0.1M PBS at pH 5. The investigation was carried out using DPV as it is depicted in Figure 6a and 253 
6b.  254 
Figure 6 255 
Figure 6a shows the electro-oxidation of AB at height positive potential +650 mV. Figure 6b 256 
illustrates the electro-oxidation of MB at height positive potential +920mV.  The peak height 257 
current (Ipa) values increases in magnitude upon the addition of AB and MB concentrations as 258 
shown in Figure 6a and b. The AB and MB concentrations range from 1 to 10.5 μM and 2.3 to 10.0 259 
μM respectively were plotted against the measured peak height current (Ipa). Figure 6a and 6b 260 
displays a good linear relationship between Ipa and AB and MB concentrations.  261 
A linear regression equation for AB was given by (Ip/µA = 2.300x + 2.116) and for MB was given 262 
by (Ip/µA = 2.949x + 1.3893) with N = 8. 263 
Table 1 depicts a summary of the statistical values for AB and MB such as the linear concentration 264 
range (LCR); regression equation (RE); coefficient of correlation (r), limit of detection (LoD) and 265 
limit of quantification (LoQ). 266 
Table 1 267 
 268 
The accuracy and selectivity of the electroanalytical method was further evaluated by preparing 269 
standard solutions enriched with placebo. Furthermore, the repeatability (intra-assay) and 270 
reproducibility (inter-day) of measurements resulted in RSD values lower than 3%, which is in 271 
agreement with the actual pharmaceutical specification for regulatory issues. As a result we can 272 
comment that the electroanalytical sensor showed an excellent degree of stability and robustness. 273 
The assays were performed in three replicas at three different concentrations 1, 3 and  274 
5 µM for AB and 2, 6 and 10 µM for MB as illustrated in Table 2. 275 
Table 2 276 
The found recovery values were very good for all concentration levels for both benzimidazoles. The 277 
percentage recovery values varied from 98% to 102% which are well within the statistical values. 278 
Therefore, the usual excipients employed for pharmaceutical formulation did not interfere on the 279 
method accuracy. 280 
3.4 Analysis of Pharmaceutical formulations  281 
Hence, the optimized method was evaluated for pharmaceutical analysis of tablets and suspensions 282 
acquired in drugstores. The samples were prepared only by dilution and filtration, with no need for 283 
exhaustive sample preparation steps. The Table 3 presents the results obtained for AB and MB 284 
medicines. 285 
Table 3 286 
Also, the accuracy of the proposed method was equivalent to the one obtained by the official 287 
method, which were performed by local quality control laboratory accordingly to the 288 
pharmacopoeia specifications. 289 
The electroanalytical protocol has been successfully applied towards the detection of AB and MB in 290 
pharmaceutical solutions. 291 
 292 
3.5 Selectivity 293 
Finally we will turn our attention to discuss selectivity, AB and MB belongs to the chemical family 294 
of benzimidazoles. In this manuscript we have reported the electrochemical detection of AB and 295 
MB without cross selectivity between them as they present different electro-oxidation responses AB 296 
oxidizes at +650mV and MB at +920mV.  297 
 298 
4. Conclusions 299 
In this manuscript we have reported for the first time the successful electroanalytical sensing of AB 300 
and MB using sonogel carbon paste electrodes modified with LaFeO3 nanoparticles in an ideal 301 
buffer solution as well as in pharmaceutical solutions.  302 
The sensor offers a long term stability and excellent reproducibility with essentially no pre-303 
treatment or maintenance towards the routine analysis of AB and MB. A linear response is observed 304 
for AB and MB over a concentrations range from 1 to 10.5 μM and 2.3 to 10.0 μM respectively in 305 
0.1M PBS at pH 5. A linear regression equation for AB was given by (Ip/µA = 2.300x + 2.116) and 306 
for MB was given by (Ip/µA = 2.949x + 1.3893) with N = 8. 307 
The electroanalytical methodology proposed in this manuscript was successfully applied towards 308 
the sensing of AB and MB in pharmaceutical solutions. Furthermore, the analyses carried out show 309 
that there was no interference of the excipients present in the pharmaceutical products.  310 
 311 
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Figure 1. Chemical structures of albendazole (A) and mebendazole (B). 404 
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Figure 2. (A) XRD pattern of LaFeO3 powder after being calcined at 550 °C for 2h and (B) FT-IR 407 
spectra of the LaFeO3 nanoparticles. 408 
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Figure 3. TEM  images for LaFeO3 nanopowders. 411 
 412 
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 429 
Figure 4. (a and b) SEM micrographs for LaFeO3 nanopowders. (c) Represents the EDS 430 
spectrum with atomic percentage in table (d). 431 
  432 
a) b) 
c) 
 
 
      
Elements % Atom 
La 5% 
Fe 10% 
O 30% 
 
0 1 2 3 4 5 6 7 8
La
Fe
Fe
La
La
Energy (keV)
Au
FeO
La
C
d) 
 433 
 434 
 435 
 436 
 
 437 
 438 
 439 
Figure 5. Differential pulse voltammograms obtained for 5μM solutions of AB (A) and MB (B) 440 
both at LaFeO3-Sonogel (─) and at bare Sonogel (- - -) carbon paste electrode in 0.1M PBS, pH 5.0. 441 
Relative response for 5μM AB in different pH buffer solutions at LaFeO3-Sonogel (C). 442 
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 447 
Figure 6. Calibration curves obtained for : A) AB  at different concentrations a→h (1 to 10.5 μM), 448 
and B) MB a→ i (2.3 to 10.0 μM) all in 0.1 M PBS, pH 5.0. Inset: the corresponding DP 449 
voltammograms for increasing concentrations of AB (A) and MB (B). 450 
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Table 1. Statistical summary of evaluated linear concentration range (LCR); regression equation 452 
(RE); coefficient of correlation (r), limit of detection (LoD) and limit of quantification (LoQ). 453 
Parameters Mebendazole Albendazole 
LCR 2.3-10.0 (μM) 1.0-10.5 (μM) 
LE Y = 2.949x+ 1.3893 Y = 2.300x+2.116 
r 0.9874 0.9961 
intra-assay (RSD %, N = 3) 1.4 1.2 
Inter-day (RSD %, N = 6) 2.7 2.5 
LoD 0.6 μM 0.3 μM 
LoQ 1.7 μM 0.8 μM 
a SD: Standard deviation of six replicate determinations, 454 
b RSD: relative standard deviation, Average of six replicate determination 455 
  456 
Table 2. Effect of placebo on the method accuracy. 457 
Sample 
Added 
(μM) 
Recovery 
Mean (μM) + SDa (%) 
AB 1.00 0.98 ±1.39 98.0 
 3.00 2.97±0.89 99.6 
 5.00 5.10±0.02 102.0 
MB 2.00 1.98 ± 0.16 99.0 
 6.00 5.95 ± 0.17 99.2 
 10.00 9.93 ± 0.22 99.3 
aSD: Standard deviation of six replicate determinations, 458 
 459 
  460 
Table 3. Results obtained in the determination of AB and MB in commercial pharmaceutical 461 
formulations (tablets and suspensions) using the proposed DPV method. 462 
Samples Dosage Form Label Concentration Found (mg) ± SD 
Recovery  
(%) 
Official Method 
Recovery (%) 
AB Tablet 1 400 mg 400.6 +  2.10 100.7 101.3 
AB  Tablet 2 200 mg 398.3 +  4.44 99.50 100.1 
AB Suspension 40 mg /mL 40.0  +  2.22 100.6 99.1 
MB Suspension 20 mg/mL 19.5 +  0.53 97.5 98.0 
MB  Tablet 500 mg 495.8 +  0.13 99.18 96.0 
SD: Standard deviation of six replicate determinations, RSD: relative standard deviation, 463 
aAverage of six replicate determinations  464 
  465 
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